NO932984L - Fettsyrebehandling - Google Patents

Fettsyrebehandling

Info

Publication number
NO932984L
NO932984L NO932984A NO932984A NO932984L NO 932984 L NO932984 L NO 932984L NO 932984 A NO932984 A NO 932984A NO 932984 A NO932984 A NO 932984A NO 932984 L NO932984 L NO 932984L
Authority
NO
Norway
Prior art keywords
fatty acid
acid treatment
treatment
prevention
acid
Prior art date
Application number
NO932984A
Other languages
English (en)
Other versions
NO932984D0 (no
Inventor
David Frederick Horrobin
Brenda Elizabeth Reynolds
Original Assignee
Scotia Holdings Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings Plc filed Critical Scotia Holdings Plc
Publication of NO932984D0 publication Critical patent/NO932984D0/no
Publication of NO932984L publication Critical patent/NO932984L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Fremgangsmåte for å hindre og/eller behandle unormal kalsifisering i et vev ved at man tilfører (i) GLA og/eller dens EFA-metabolitter, og da spesielt det hurtigproduserte DGLA, og/eller (ii) EPA og/eller dets forløpere, stearidonsyre og 20:4 n-3, og metabolitter, dokosaheksansyre (DHA) eller dokosapentansyre (22:5 n-3), enten som sådanne eller i form av et salt eller en annen farmakologisk akseptabel form. Denne fremgangsmåten er spesielt godt egnet for å hindre eller å behandle nevrokalsinose og/eller nyresten.
NO932984A 1992-08-21 1993-08-20 Fettsyrebehandling NO932984L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929217781A GB9217781D0 (en) 1992-08-21 1992-08-21 Fatty acid treatment

Publications (2)

Publication Number Publication Date
NO932984D0 NO932984D0 (no) 1993-08-20
NO932984L true NO932984L (no) 1994-02-22

Family

ID=10720717

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932984A NO932984L (no) 1992-08-21 1993-08-20 Fettsyrebehandling

Country Status (17)

Country Link
EP (1) EP0585027B1 (no)
JP (1) JPH06172169A (no)
KR (1) KR940003552A (no)
CN (1) CN1090490A (no)
AT (1) ATE164518T1 (no)
AU (1) AU666748B2 (no)
CA (1) CA2104566A1 (no)
DE (1) DE69317716T2 (no)
DK (1) DK0585027T3 (no)
ES (1) ES2117104T3 (no)
GB (1) GB9217781D0 (no)
GR (1) GR3026708T3 (no)
MY (1) MY131357A (no)
NO (1) NO932984L (no)
NZ (1) NZ248451A (no)
RU (1) RU2122408C1 (no)
ZA (1) ZA936133B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2119000A1 (en) * 1993-03-19 1994-09-20 David Frederick Horrobin Formulation for use in smokers
US5668174A (en) * 1993-12-29 1997-09-16 Kowa Tekuno Sachi Co., Ltd. Method of treating hyperparathyroidism
KR19980701452A (ko) * 1995-01-18 1998-05-15 우에하라 아끼라 피부염 치료제(Remedy for Dermatitis)
GB9617847D0 (en) 1996-08-27 1996-10-09 Scotia Holdings Plc Fatty acid treatment
JP4607264B2 (ja) * 1998-12-01 2011-01-05 生化学工業株式会社 ヒアルロン酸を有効成分とする異所性石灰化抑制剤
GB0016045D0 (en) * 2000-06-29 2000-08-23 Laxdale Limited Therapeutic combinations of fatty acids
CA2446059C (en) * 2001-05-14 2010-03-23 Dsm Ip Assets B.V. Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes
FR2839887A1 (fr) 2002-05-22 2003-11-28 Synergia Nouvelles compositions nutraceutiques et pharmaceutiques et leurs utilisations
JP4575105B2 (ja) * 2004-10-07 2010-11-04 ポリエン・プロジェクト有限会社 骨芽細胞活性抑制剤
CN103202483A (zh) * 2012-01-11 2013-07-17 浙江康恩贝健康产品有限公司 一种补钙营养组合物
EP2861227A4 (en) 2012-06-17 2016-01-27 Matinas Biopharma Inc OMEGA-3 PENTAIC ACID COMPOSITIONS AND METHODS OF USE
CA3024191C (en) * 2016-06-01 2024-05-28 Nestec S.A. Composition for use in the prophylaxis of allergic disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0150248B1 (de) * 1984-02-01 1988-10-19 T P O "Pharmachim" Mittel zur Behandlung und Prophylaxe uratischer und gemischter uratischer Lithiasis
GB8607749D0 (en) * 1986-03-27 1986-04-30 Hetherington A M Compounds & pharmaceutical preparations
DE3781686T2 (de) * 1986-05-02 1993-03-11 Brigham & Womens Hospital Fettsaeure und cyclosporin enthaltende zusammensetzung mit ermaessigter nephrotoxizitaet.
GB9112052D0 (en) * 1991-06-05 1991-07-24 Efamol Holdings Fatty acid treatment

Also Published As

Publication number Publication date
ATE164518T1 (de) 1998-04-15
RU2122408C1 (ru) 1998-11-27
CN1090490A (zh) 1994-08-10
DE69317716D1 (de) 1998-05-07
MY131357A (en) 2007-08-30
JPH06172169A (ja) 1994-06-21
DE69317716T2 (de) 1998-09-17
NO932984D0 (no) 1993-08-20
AU666748B2 (en) 1996-02-22
DK0585027T3 (da) 1998-05-11
GB9217781D0 (en) 1992-10-07
EP0585027A1 (en) 1994-03-02
CA2104566A1 (en) 1994-02-22
AU4474893A (en) 1994-02-24
EP0585027B1 (en) 1998-04-01
NZ248451A (en) 1997-07-27
ES2117104T3 (es) 1998-08-01
KR940003552A (ko) 1994-03-12
GR3026708T3 (en) 1998-07-31
ZA936133B (en) 1994-03-17

Similar Documents

Publication Publication Date Title
MY109928A (en) Fatty acid treatment
IS5017A (is) Lyfjasamsetning sem inniheldur eikósapentaensýru og/eða stearidónsýru
ATE43242T1 (de) Pharmazeutische oder diaetetische zusammensetzung mit hoher antithrombotischer und antiarteriosklerotischer wirkung.
NZ299464A (en) Use of gamma linolenic or dihomogamma linolenic acid in the treatment of Huntington's Chorea
GB8319073D0 (en) Fatty acid compositions
ATE98125T1 (de) Zusammensetzungen essentieller fettsaeuren und therapie.
NO932984D0 (no) Fettsyrebehandling
JPS6422819A (en) Amnesia treating or preventing composition
DK0623019T3 (da) Medikamenter på basis af docosahexaensyre som midler mod blodpladeaggregation og mod cerebral mangel på essentielle fedtsyr
RU93049092A (ru) Лечение жирными кислотами
ATE142491T1 (de) Mittel zur behandlung des atopischen ekzems und anderen entzündlichen hautkrankheiten
MY129218A (en) Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid